Skip to main content

Table 3 Exacerbations and psychosocial impact

From: Chronic obstructive pulmonary disease and exacerbations: Patient insights from the global Hidden Depths of COPD survey

 

MRC 1 and 2

MRC 3, 4 and 5

(n=1,231)

(n=769)

Proportion of patients with an exacerbation, n (%)

 Ever

875 (71%)

659 (86%)

 In the last 12 months

760 (62%)

617 (80%)

Proportion of people hospitalised by an exacerbation (baseline: n=875 & 659), n (%)

239 (27%)

342 (52%)

Time taken to return to normal after an exacerbation (baseline: n=875 & 659), n (%)

 Within a few days

450 (51%)

266 (40%)

 Within a week

255 (29%)

169 (26%)

 Within a few weeks

104 (12%)

150 (23%)

 Within a month

28 (3%)

18 (3%)

 Within a few months

16 (2%)

14 (2%)

 Longer

7 (1%)

3 (0%)

 Never

15 (2%)

39 (6%)

Patient reaction to the onset of an exacerbation (baseline: n=875 & 659), n (%)

 Take action right away

493 (56%)

379 (58%)

 Wait and see

345 (39%)

246 (37%)

 Do nothing

37 (4%)

34 (5%)

Patient concern for long-term health as a consequence of having COPD, n (%)

 Not at all worried

38 (3%)

16 (2%)

 Not particularly worried

112 (9%)

25 (3%)

 Neither worried nor unworried

167 (14%)

94 (12%)

 Somewhat worried

671 (55%)

358 (47%)

 Extremely worried

236 (19%)

271 (35%)

Patient fear of premature death from COPD, n (%)

 Not at all scared

171 (14%)

59 (8%)

 Not particularly scared

536 (44%)

230 (30%)

 Quite scared

368 (30%)

319 (41%)

 Very scared

101 (8%)

134 (17%)

Fear of premature death from an exacerbation (baseline: n=875 & 659), n (%)

 Not at all scared

110 (13%)

47 (7%)

 Not particularly scared

327 (37%)

176 (27%)

 Quite scared

305 (35%)

267 (41%)

 Very scared

104 (12%)

149 (23%)

  1. MRC=Medical Research Council breathlessness scale; COPD=chronic obstructive pulmonary disease.